henhaobio
Sign in

Journal of NeuroinflammationNeurosciencePeer-reviewed journal article

Metabolic reprogramming and altered ATP content impair neuroprotective functions of microglia in β-glucocerebrosidase deficiency models

Electra BrunialtiiD, Alessandro Maria VillaiD, Éva M. SzegőiD, Pietro La VitolaiD, Denise DragoiD, Radmila PavlovićiD, Laura FontanaiD, Doga Tuna, Alessia PanzeriiD, Clara MedaiD, Christin WeisslederiD, Ornella RondinoneiD, Mattia PitasiiD, Monica Rosa MiozzoiD, Michela DeleidiiD, Annapaola AndolfoiD, Donato A. Di MonteiD, Paolo CianaiD

PDFDOIPreprint

Abstract

Mutations in the GBA gene, which reduce {beta}-glucocerebrosidase (GCase) activity, represent the most significant genetic risk factor for Parkinsons disease (PD). Decreased GCase activity has also been observed in sporadic PD cases, supporting a broader role for GCase in the poorly understood mechanisms underlying PD etiopathogenesis. While most studies on the relationship between GBA mutations and PD have focused on neurons, evidence suggests that PD pathology promoted by GCase deficiency involves other cell types and, in particular, interactions between neuronal and glial cells. Here, we identify microglia as primary players undergoing significant alterations at early stages of the pathological processes triggered by a GCase impairment. Using both pharmacological and genetic mouse models of GCase deficiency, we observed microglial morphological, transcriptional and metabolic changes. Interestingly, these changes were associated with a cell-specific, significant reduction of microglial ATP levels. When microglial ATP depletion was reproduced in an in vitro system of co-cultured microglial and neuronal cells, the neuroprotective properties of microglia were compromised and neuronal susceptibility to oxidative stress was enhanced. These findings underscore the role of microglia in PD pathogenesis and point to a pathogenetic mechanism by which microglial metabolic disturbances leading to ATP depletion enhance neuronal vulnerability to injury and neurodegeneration. This mechanism could be targeted for therapeutic intervention aimed at mitigating PD risk and counteracting the development of PD pathology. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=112 SRC="FIGDIR/small/656111v2_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@dfd3d7org.highwire.dtl.DTLVardef@ccf2c2org.highwire.dtl.DTLVardef@155d241org.highwire.dtl.DTLVardef@15ed00a_HPS_FORMAT_FIGEXP M_FIG C_FIG

Citations
4
FWCI
1.43
Field percentile
top 18%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISBrunialti '21Brunialti '23Tahanis '25Vincow '24Mistry '22Wang '25
79% semantic matchNeuroscience
Electra Brunialti, Alessandro Maria Villa, Marianna Mekhaeil+5 more·Journal of Neuroinflammation·Sep 22, 2021· 30 citations